ANGIODYNAMICS INC — Director's Dealing 2014

Nov 10, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2014-10-29

Reporting Person: Trowbridge Stephen A (SVP and General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25765	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$15.27	2015-08-06	Common Stock (5800)		Direct
Non-Qualified Stock Option (right to buy)	$11.92	2020-08-06	Common Stock (17470)		Direct
Non-Qualified Stock Option (right to buy)	$14.07	2021-07-25	Common Stock (13625)		Direct
Performance Right	$0		Common Stock (7151)		Direct
Performance Right	$0		Common Stock (6314)		Direct

Footnotes

F1: This number includes 14,883 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") underlying restricted stock units, of which (i) 3,625 shares will vest on August 3, 2015; (ii) 2,500 shares will vest on August 3, 2016; (iii) 1,341 shares will vest on each of August 6, 2015, 2016 and 2017; (iv) 1,183 shares will vest on July 25, 2015; and (v) 1,184 shares will vest on each of July 25, 2016, 2017 and 2018.

F2: These stock options vest in four annual installments beginning on August 6, 2014, such that 4,368 options vested on August 6, 2014, 4,368 options will vest on August 6, 2015, and 4,367 options will vest on each of August 6, 2016 and 2017.

F3: These stock options vest in four annual installments beginning on July 25, 2015, such that 3,407 options will vest on July 25, 2015, and 3,406 options will vest on each of July 25, 2016, 2017 and 2018.

F4: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is indicated in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2014, 2015 and 2016. A portion of the shares may be earned based on performance in each year of the performance period. Any shares that do not vest at the end of the performance period will be forfeited.

F5: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2015, 2016 and 2017. Any shares that do not vest at the end of the performance period will be forfeited.